Leigh Maddox
Family · Canton, GANPI 1811131204
Payments from drug & device makers
Across 85 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Insmed, Inc.$125
- Novo Nordisk$121
- Lilly USA, LLC$110
- Axsome Therapeutics, Inc.$104
- AbbVie$97
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$88
- plus $994 from 31 others
What the payments were for
- Food & beverage$1,57396%
- Education$654%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,638 in reported general payments places this provider in the 75th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 98 | $159,958 |
| MounjaroTirzepatide | 57 | $93,597 |
| JardianceEmpagliflozin | 60 | $72,476 |
| TrulicityDulaglutide | 28 | $42,149 |
| RybelsusSemaglutide | 20 | $30,366 |
| FarxigaDapagliflozin Propanediol | 23 | $26,272 |
| TradjentaLinagliptin | 14 | $20,224 |
| JanuviaSitagliptin Phosphate | 20 | $20,043 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 92 | $14,782 |
| Novolog FlexpenInsulin Aspart | 34 | $11,142 |
| EliquisApixaban | 13 | $10,944 |
| Humalog Kwikpen U-100Insulin Lispro | 23 | $8,261 |
| SynthroidLevothyroxine Sodium | 54 | $6,006 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $3,337 |
| NovologInsulin Aspart | 11 | $3,322 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $121 | $193,647129 claims |
| Lilly USA, LLCMounjaro, Trulicity, Insulin Lispro | $110 | $137,37497 claims |
| Boehringer IngelheimJardiance, Tradjenta | $21 | $92,69974 claims |
| AstraZenecaFarxiga | $83 | $26,27223 claims |
| PfizerEliquis | $24 | $10,94413 claims |
| AbbVieSynthroid | $97 | $6,00654 claims |
| Sanofi-aventis U.S. LLCLantus | $24 | $2,53811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,258 family providers in Georgia.
Other family in Canton
- Jessica FeehanCanton$51K
- Julia ThorneCanton$39K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.